Multiple myeloma - carfilzomib (with lenalidomide and dexamethasone, after prior therapy) [ID677]
Discontinued
Reference number: GID-TAG511
Please note that following on from advice received from the company this appraisal has been rescheduled. Therefore, we now anticipate that the appraisal will begin during mid October 2015 when we will write to you about how you can get involved. The deadline for submissions is expected in approximately mid December 2015.